Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fresenius SE & Co KGaA (OTCQX International Premier:FSNUY)

Delayed Data
As of Feb 22
 +0.40 / +2.00%
Today’s Change
Today|||52-Week Range
Health Services
Medical/Nursing Services

Company Description

Fresenius SE & Co. KGaA engages in the provision of healthcare related products and services. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment provides dialysis products and services. The Fresenius Kabi segment specializes in intravenously administered generic drugs, clinical nutrition, and infusion therapies. The Fresenius Helios segment operates acute and maximum care hospitals as well as post-acute care clinics. The Fresenius Vamed segment manages projects and offers services for hospitals and other healthcare facilities. The Corporate and Other segment comprises the holding activities of the company and the information technology service provider Fresenius Netcare. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Contact Information

Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
Bad Homburg Hessen 61352
P:(496) 172-6080
Investor Relations:



Other institutional0.08%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Stephan SturmChief Executive Officer
Jürgen GötzChief Legal, Compliance & Human Resources Officer
Rice PowellMember-Management Board
Francesco de MeoMember-Management Board
Ernst WastlerMember-Management Board